Logo image
Surface modification of a polymeric contrast agent for cancer targeting
Conference proceeding

Surface modification of a polymeric contrast agent for cancer targeting

L.M Leodore, K.L Oum, J.D Lathia, M.A Wheatley and IEEE
Proceedings of the IEEE 31st Annual Northeast Bioengineering Conference, 2005
2005

Abstract

Breast cancer Drug delivery In vitro Peptides Polymers Programmable logic arrays Sequences Tumors Ultrasonic imaging Vehicles
In order to develop a targeted contrast agent that enhances ultrasound images, polylactic acid (PLA) microcapsules were coated with fibronectin peptide sequences. The microcapsules were coated with either GRGDS or REDV peptide sequences that target integrins expressed in angiogensis, /spl alpha//sub v//spl beta//sub 3/ and /spl alpha//sub v//spl beta//sub 5/. Preliminary in vitro (static and flow regimes) results indicate that the modified capsules remain highly echogenic and adhere to the breast cancer cell line MDA-MB-231 as opposed to unmodified control capsules. Specific targeting of ultrasound contrast agents could be used as a means of targeted imaging for tumor cells and potentially as a drug delivery vehicle.

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Engineering, Biomedical
Logo image